The risk of endophthalmitis following intravitreal triamcinolone injection in the DRCRnet and SCORE clinical trials
about
Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusionOne-year results of bevacizumab intravitreal and posterior sub-Tenon injection of triamcinolone acetonide with reduced laser fluence photodynamic therapy for retinal angiomatous proliferation.Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalitiesRisk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials.Novel Pharmacologic Approaches for the Management of Diabetic RetinopathyDiabetic retinopathy (treatment)Drug treatment of macular oedema secondary to central retinal vein occlusion: a network meta-analysis.Corticosteroid use for diabetic macular edema: old fad or new trend?Endophthalmitis: state of the art.Advances in the management of diabetic macular oedema based on evidence from the Diabetic Retinopathy Clinical Research NetworkCurrent intravitreal pharmacologic therapies for diabetic macular edema.Diabetic retinopathy: intravitreal vascular endothelial growth factor inhibitors for diabetic macular oedema.The Association between Intravitreal Steroids and Post-Injection Endophthalmitis Rates.Topical azithromycin or ofloxacin for endophthalmitis prophylaxis after intravitreal injectionA European perspective on topical ophthalmic antibiotics: current and evolving options.Impact of antibiotic resistance in the management of ocular infections: the role of current and future antibiotics.Endophthalmitis after intravitreal injections.Treatments for macular oedema following central retinal vein occlusion: systematic review.Clinical review: Update on treatment of inflammatory macular edema.Endophthalmitis following intravitreal injections.Delivery of intraocular triamcinolone acetonide in the treatment of macular edema.Sterile endophthalmitis rates and particle size analyses of different formulations of triamcinolone acetonide.Study of the Acute Effects of Povidone-Iodine on Conjunctival Bacterial FloraAn outbreak of Ralstonia pickettii endophthalmitis following intravitreal methotrexate injection.Transporter targeted gatifloxacin prodrugs: synthesis, permeability, and topical ocular delivery.Intravitreal triamcinolone for intraocular inflammation and associated macular edema.Pharmacotherapeutic efficacy of preservative-free intravitreal triamcinolone acetonide.Current Advances in Pharmacotherapy and Technology for Diabetic Retinopathy: A Systematic Review.Emerging pharmacotherapies for diabetic macular edema
P2860
Q24240914-8F81A2D3-6B45-4E23-898F-372511716E2DQ31092005-4E75C960-C054-4A05-86B9-46BB0E40729AQ33320830-11B75B23-7DB8-42EC-894E-F052F6734550Q33518324-71F8368C-A75C-48FB-BD34-5247E8A76DEEQ33751308-5B87B425-31EC-432C-AF8D-510A1BDCD304Q33910631-F2737E42-48AB-43B5-8F89-7114698CCA49Q33995887-7233146A-79C9-4028-A00D-E6EC590A6E16Q34267270-FD1DAD0B-B579-493B-B3DF-4F3AEC2BE050Q34952098-0F67D473-2250-489F-8FCD-4D019BEEBDE2Q35649512-D9485869-40B4-411C-BA0D-F03D14C9A601Q35650268-189BABC7-C9CE-48D2-B80F-AEB0741B0247Q35975239-8382C38E-0D6C-4B1D-8668-C21DF47E7F1FQ36217662-B6A050B8-E8AB-47E5-8682-A2EE55282578Q36326803-563ED21A-035D-4E09-B497-6514810B67BEQ36867161-B6B3D605-AE42-4B1A-ADF0-FCA88959E886Q37367643-E6085D77-5B1D-4082-B0D4-44077BA916DDQ37544827-5F1193D0-6252-4471-9196-2F613969A95CQ37590692-9E8CE185-C49B-4F9C-B5A1-A7B81687A980Q37804876-ED660CBB-B5F8-4F0D-8B8F-D14DF19C5565Q37952079-F22352F5-43BF-4EF2-9681-86C58A1C0FF1Q38168356-C79658A9-2073-4EAC-ACC1-A3FC05871A65Q40821399-7A1D34CA-F3A2-4A47-AC41-A09F5EB13FE5Q41044420-88DD9544-5111-422B-B3F7-B72893F72F8BQ41606615-5F69F750-F9F6-41F0-9C20-5F2168819903Q41841013-5CC603E2-768E-4476-B8E7-298F1F1D07A2Q43096392-DF82CFC0-698A-4259-AAA8-550FEAE74777Q43225793-3126E91A-82F1-420B-9308-35512CF3E76AQ52632539-226981DD-B664-405C-9517-C98B1AB57B1DQ58907881-B9266A0E-9D88-4F7C-B53F-C948A363CEDD
P2860
The risk of endophthalmitis following intravitreal triamcinolone injection in the DRCRnet and SCORE clinical trials
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The risk of endophthalmitis fo ...... Rnet and SCORE clinical trials
@ast
The risk of endophthalmitis fo ...... Rnet and SCORE clinical trials
@en
type
label
The risk of endophthalmitis fo ...... Rnet and SCORE clinical trials
@ast
The risk of endophthalmitis fo ...... Rnet and SCORE clinical trials
@en
prefLabel
The risk of endophthalmitis fo ...... Rnet and SCORE clinical trials
@ast
The risk of endophthalmitis fo ...... Rnet and SCORE clinical trials
@en
P2093
P2860
P1476
The risk of endophthalmitis fo ...... Rnet and SCORE clinical trials
@en
P2093
Abdhish R Bhavsar
Adam R Glassman
DRCRnet and the SCORE Study Groups
Michael S Ip
P2860
P304
P356
10.1016/J.AJO.2007.04.011
P407
P577
2007-09-01T00:00:00Z